Liver transplantation for advanced-stage primary hepatic yolk sac tumor: A case report and literature review.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
15 Dec 2023
15 Dec 2023
Historique:
medline:
20
12
2023
pubmed:
20
12
2023
entrez:
20
12
2023
Statut:
ppublish
Résumé
Primary hepatic yolk sac tumors (YSTs) are rare in adults. Liver resection is an acknowledged treatment modality for primary hepatic YST. Liver transplantation may offer a possible cure for unresectable cases. We present a case of a 31-year-old woman with an abdominal mass who had abnormally elevated alpha-fetoprotein (AFP) levels (31,132 ng/mL; normal: 0-7 ng/mL). Contrast-enhanced computed tomography (CT) revealed large tumors located in both lobes of the liver, with arterial enhancement and venous washout. Fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/CT indicated increased 18F-FDG uptake (maximum standardized uptake value, 24.4) in the liver tumors and left middle intra-abdominal nodule. The diagnosis was primary hepatic YST with metastasis to the greater omentum. The patient underwent orthotopic liver transplantation and intra-abdominal nodule resection after transarterial chemoembolization (TACE) as a bridge. Intraoperatively, an intra-abdominal nodule was confirmed in the greater omentum. Histopathological examination of the liver tumors revealed Schiller-Duval bodies. The tropomyosin receptor kinase (TRK) inhibitor larotrectinib was administered, followed by four cycles of chemotherapy with bleomycin, etoposide, and cisplatin based on the next-generation sequencing results. The AFP level decreased to within the normal range. No evidence of tumor collapse was observed during the 34-month follow-up period. This case suggests that multimodal therapy dominated by liver transplantation, including preoperative TACE, postoperative adjuvant chemotherapy, and TRK inhibitors, is an effective treatment modality for unresectable primary hepatic YST.
Identifiants
pubmed: 38115376
doi: 10.1097/MD.0000000000035821
pii: 00005792-202312150-00137
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e35821Informations de copyright
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
McKenney JK, Heerema-McKenney A, Rouse RV. Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations. Adv Anat Pathol. 2007;14:69–92.
O’Sullivan P, Daneman A, Chan HS, et al. Extragonadal endodermal sinus tumors in children: a review of 24 cases. Pediatr Radiol. 1983;13:249–57.
Natori T, Teshima S, Kikuchi Y, et al. Primary yolk sac tumor of the liver An autopsy case with ultrastructural and immunopathological studies. Acta Pathol Jpn. 1983;33:555–64.
Narita T, Moriyama Y, Ito Y. Endodermal sinus (yolk sac) tumor of the liver a case report and review of the literature. J Pathol. 1988;155:41–7.
Villaschi S, Balistreri P. Endodermal sinus tumor of the liver. Histopathology. 1991;18:86–8.
Whelan JS, Stebbings W, Owen RA, et al. Successful treatment of a primary endodermal sinus tumor of the liver. Cancer. 1992;70:2260–2.
Higuchi T, Kikuchi M. Yolk sac tumor of the liver treated with transcatheter arterial embolization. Am J Gastroenterol. 1993;88:1125–6.
Wong NA, D’Costa H, Barry RE, et al. Primary yolk sac tumor of the liver in adulthood. J Clin Pathol. 1998;51:939–40.
Gunawardena SA, Siriwardana HPP, Wickramasinghe SYLS, et al. Primary endodermal sinus (yolk sac) tumor of the liver. Eur J Surg Oncol. 2002;28:90–1.
Toumi N, Chaumette-Plankaert M-T, Cherqui D, et al. Case 3 Primary yolk sac tumor of the liver. J Clin Oncol. 2004;22:1756–8.
Lenci I, Tariciotti L, Baiocchi L, et al. Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma. Transpl Int. 2008;21:598–601.
Hosala M, Laca L, Hosalova Matisova J, et al. Primary yolk sac tumor of liver with unusual clinical presentation mimicking acute appendicitis. Acta Med Marisiensis. 2014;13:33–7.
Reznichenko AA, Klingbeil LR, Shah SA. Giant primary yolk sac tumor of the liver. J Gastrointest Surg. 2016;20:1669–70.
Evers L, Patel D, Porayko M. An unusual cause of liver mass in a female. Gastroenterology. 2018;155:e17–8.
Prilutskiy A, Tan J, Zhao Q. A case report on a primary hepatic yolk sac tumor in a middle-aged woman—a challenging diagnosis. Am J Clin Pathol. 2018;149(Suppl 1):S115.
Vanidassane I, Sharma V, Ramteke P, et al. Primary yolk sac tumor of the liver in an adult man. ACG Case Rep J. 2019;6:e00050.
Jindal A, Mukund A, Bihari C. Primary yolk sac tumor of liver. Liver Int. 2021;41:2212–3.
Morinaga S, Nishiya H, Inafuku T. Yolk sac tumor of the liver combined with hepatocellular carcinoma. Arch Pathol Lab Med. 1996;120:687–90.
Sumazin P, Peters TL, Sarabia SF, et al. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022;77:1026–37.
Litten JB, Tomlinson GE. Liver tumors in children. Oncologist. 2008;13:812–20.
Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.
Zsiros J, Maibach R, Shafford E, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol. 2010;28:2584–90.
Abramson LP, Pillai S, Acton R, et al. Successful orthotopic liver transplantation for treatment of a hepatic yolk sac tumor. J Pediatr Surg. 2005;40:1185–7.